Cargando…

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma

PURPOSE: Stomach cancer is one of the highest incidence and mortality malignancies worldwide. Our study aimed to illustrate the somatic mutation landscape and identify molecular markers of stomach cancer. MATERIALS AND METHODS: By integrated analysis of sequencing data and clinical data of stomach a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiulei, Zheng, Peiming, Li, Zhen, Gao, Shanjun, Liu, Guangzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414981/ https://www.ncbi.nlm.nih.gov/pubmed/32801780 http://dx.doi.org/10.2147/OTT.S263733

Ejemplares similares

Identification and Analysis of Estrogen Receptor α Promoting Tamoxifen Resistance-Related lncRNAs
por: Zhang, Xiulei, et al.
Publicado: (2020)

Somatic Mutation of FAT Family Genes Implicated Superior Prognosis in Patients With Stomach Adenocarcinoma
por: Wang, Qingjun, et al.
Publicado: (2022)

MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis
por: Luo, Wen-Zhao, et al.
Publicado: (2023)

Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance
por: Tong, Xiaoxia, et al.
Publicado: (2022)

Prognostic significance of preoperative serum tumor markers in hepatoid adenocarcinoma of stomach (HAS)
por: Yang, Xuesong, et al.
Publicado: (2023)

Clinicopathological and Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Yang, Jinlin, et al.
Publicado: (2014)

Antimicrobial Activity of Lemongrass Essential Oil (Cymbopogon flexuosus) and Its Active Component Citral Against Dual-Species Biofilms of Staphylococcus aureus and Candida Species
por: Gao, Shanjun, et al.
Publicado: (2020)

Prognostic Value and Biological Functions of RNA Binding Proteins in Stomach Adenocarcinoma
por: Li, Junqing, et al.
Publicado: (2021)

Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma
por: Tan, Ruoyue, et al.
Publicado: (2021)

The somatic mutation landscape of Chinese Colorectal Cancer
por: Ma, Rong, et al.
Publicado: (2020)

TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma
por: Zhang, Xiulei, et al.
Publicado: (2021)

Influence of Prognostic Factors for Recurrence of Adenocarcinoma of the Stomach
por: Mehmedagic, Indira, et al.
Publicado: (2016)

Domain landscapes of somatic mutations in cancer
por: Nehrt, Nathan L, et al.
Publicado: (2012)

The somatic mutation landscape of the human body
por: García-Nieto, Pablo E., et al.
Publicado: (2019)

Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
por: Geng, Wei, et al.
Publicado: (2021)

Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients
por: Zha, Zhiqiang, et al.
Publicado: (2021)

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

Prognostic Value and Potential Regulatory Mechanism of H19 in Stomach Adenocarcinoma
por: Guo, Hongyuan, et al.
Publicado: (2022)

DNA cytosine deamination is associated with recurrent Somatic Copy Number Alterations in stomach adenocarcinoma
por: Shi, Yilin, et al.
Publicado: (2023)

Identification of miRNA biomarkers for stomach adenocarcinoma
por: Qian, Hao, et al.
Publicado: (2022)

Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas
por: Zheng, Guo-Liang, et al.
Publicado: (2022)

Oncogenic Landscape of Somatic Mutations Perturbing Pan-Cancer lncRNA-ceRNA Regulation
por: Zhang, Yuanfu, et al.
Publicado: (2021)

A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas With Large Genetic Heterogeneity Using Somatic Mutation Features
por: Liu, Xianming, et al.
Publicado: (2020)

Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach
por: Huang, Wen-peng, et al.
Publicado: (2021)

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma
por: Huang, Yong, et al.
Publicado: (2022)

The somatic mutation landscape of premalignant colorectal adenoma
por: Lin, Shu-Hong, et al.
Publicado: (2018)

The evolving landscape of prostate cancer somatic mutations
por: Cotter, Kellie, et al.
Publicado: (2022)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

The landscape of somatic mutations in lymphoblastoid cell lines
por: Caballero, Madison, et al.
Publicado: (2023)

Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma
por: Tang, Fenfen, et al.
Publicado: (2022)

The landscape of somatic mutation in sporadic Chinese colorectal cancer
por: Liu, Zhe, et al.
Publicado: (2018)

Plasma Exosomal Long Noncoding RNA lnc-SLC2A12-10:1 as a Novel Diagnostic Biomarker for Gastric Cancer
por: Zheng, Peiming, et al.
Publicado: (2020)

Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma
por: Gao, Liuying, et al.
Publicado: (2022)

Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach
por: Lin, Jian-Xian, et al.
Publicado: (2021)

A novel microRNA signature predicts survival in stomach adenocarcinoma
por: Ding, Bowen, et al.
Publicado: (2017)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022)

Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma
por: Zhu, Ya-Zhen, et al.
Publicado: (2022)

LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)

S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus
por: Treese, Christoph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ce7mlgm3nqud7dndc6ak565k61